Healthcare Stocks

Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

 Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

Pharma and biotech-focused companies have seen huge investments after the onset of the pandemic. The UK received record levels of investment into its life sciences sector in 2021, with VC (Venture Capital) and PE (Private Equity) investment into th...

Read More...
Five Healthcare Stocks to Consider- Synairgen, Novacyt, Avacta Group, Okyo Pharma, and E-Therapeutics

Five Healthcare Stocks to Consider- Synairgen, Novacyt, Avacta Group, Okyo Pharma, and E-Therapeutics

Summary The outbreak of the pandemic has led to a change in consumer preferences and priorities as the focus has shifted towards the use of technology and contact-less healthcare services The current reporting season has been challenging for ma...

Read More...
AstraZeneca Rekindles the Hope of Vaccine After A Voluntary Halt in Late-Stage Trial

AstraZeneca Rekindles the Hope of Vaccine After A Voluntary Halt in Late-Stage Trial

Summary AstraZeneca Plc after a voluntary halt in the phase 3 trial of its coronavirus vaccine has said that the Covid-19 vaccine could still be available the end of the year The UK-based pharmaceutical company is involved in the Covid-19 vacci...

Read More...
What next as AstraZeneca stops trials for its Covid-19 vaccine?

What next as AstraZeneca stops trials for its Covid-19 vaccine?

AstraZeneca plc (LON: AZN) has put on hold the phase 3 trials of its Covid-19 vaccine candidate, AZD1222, due to a suspected unfavorable reaction being developed in a UK volunteer. The vaccine maker has halted the vaccine trials voluntarily to faci...

Read More...
CTEC, TSTL, IDH and SN. In Focus as Medical Devices to Require A New UK Product Safety Marking

CTEC, TSTL, IDH and SN. In Focus as Medical Devices to Require A New UK Product Safety Marking

  Health care equipment & devices manufacturers/ distributors are likely to bear some additional cost and efforts due to the new UK product safety marking. The medical supplies, along with health care devices and equipment, were being tra...

Read More...
Two Healthcare Stocks Trending on LSE: Dechra Pharmaceuticals PLC & Diaceutics PLC

Two Healthcare Stocks Trending on LSE: Dechra Pharmaceuticals PLC & Diaceutics PLC

Summary Dechra Pharmaceuticals revenue increased by 6.8 percent year on year in FY2020, which was supported by the full-year impact of the acquisitions. The underlying EBITDA was £142.5 million, and the EBITDA margin was 27.7 percent in F...

Read More...
AstraZeneca-Oxford Vaccine to Roll Out by Early Next Year, Other Vaccines Also Advance to Next Stage

AstraZeneca-Oxford Vaccine to Roll Out by Early Next Year, Other Vaccines Also Advance to Next Stage

Summary The AstraZeneca licenced Jenner Institute of Oxford University developed vaccine candidate is in the most advanced stage of its clinical trials compared to its most other competitors being developed around the world. The vaccine’s...

Read More...
5 Vaccine Stocks Doing Well in the UK

5 Vaccine Stocks Doing Well in the UK

Summary Several pharmaceutical companies are conducting clinical and human trials to test an effective vaccine for Covid-19. Some of the companies including AstraZeneca, GSK, Johnson & Johnson, Pfizer, and Sanofi are doing good both in term...

Read More...
Four FTSE 100 Healthcare Stocks to Keep an Eye On – AstraZeneca GlaxoSmithKline, Hikma and Smith & Nephew

Four FTSE 100 Healthcare Stocks to Keep an Eye On – AstraZeneca GlaxoSmithKline, Hikma and Smith & Nephew

Summary Healthcare is perhaps the only one of the few sectors which are in the thick of business activity in these trying times in the United Kingdom. UK is home to some global pharmaceutical giants which have unparalleled technological advance...

Read More...
Two FTSE Listed Healthcare Stocks in Limelight – 4D Pharma PLC & N4 Pharma PLC

Two FTSE Listed Healthcare Stocks in Limelight – 4D Pharma PLC & N4 Pharma PLC

Summary  4D Pharma announced clinical trial benefit in Phase A trial from the combined use of MRx0518 and Keytruda®. Also, disease control rate of 42 percent in 12 patients was achieved in Phase A trial. The Company is undergoing Phase...

Read More...
USFDA Approval for AstraZeneca Vaccine Bring Cheer at FTSE 100 as well

USFDA Approval for AstraZeneca Vaccine Bring Cheer at FTSE 100 as well

Summary Equity markets across the globe turned jubilant on hopes about the early improvement on the pandemic front The USFDA approval for the AstraZeneca candidate ahead of its American contender, Moderna's much-hyped candidate, raises hoped of...

Read More...